Further elucidation of the signalling and transcriptional events which regulate EHF and CDX1 expression may therefore further unveil the hierarchy of differentiation loss in CRC, and uncover potential therapeutic strategies for CRC based on the re-induction of EHF/CDX1-driven tumour differentiation. This evidence concerns the gene EHF and colorectal carcinoma.